Literature DB >> 2235141

Treatment considerations for children with human immunodeficiency virus infection.

P A Pizzo1, C M Wilfert.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1990        PMID： 2235141     DOI： 10.1097/00006454-199010000-00002

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN： 0891-3668            Impact factor:   2.129


× No keyword cloud information.
  4 in total

Review 1.  HIV infection in children.

Authors:  D Gibb; M L Newell
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  Pneumocystis prophylaxis for all, some, or no HIV-infected infants less than one year of age: A decision analysis approach.

Authors:  U D Allen; S E Read
Journal:  Can J Infect Dis       Date:  1993-11

Review 3.  Zidovudine. An update of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.

Authors:  Michelle I Wilde; Heather D Langtry
Journal:  Drugs       Date:  1993-09       Impact factor: 9.546

Review 4.  Zalcitabine. A review of its pharmacology and clinical potential in acquired immunodeficiency syndrome (AIDS).

Authors:  R Whittington; R N Brogden
Journal:  Drugs       Date:  1992-10       Impact factor: 9.546
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.